![]() |
市場調査レポート
商品コード
1754154
多毛症市場レポート:治療タイプ、製品、エンドユーザー、地域別、2025年~2033年Hirsutism Market Report by Therapy Type (Procedures, Medication), Products (Hair Removal Equipment, Topical Hair Removal Products, and Others), End User (Hospitals, Clinics, and Others), and Region 2025-2033 |
||||||
カスタマイズ可能
|
多毛症市場レポート:治療タイプ、製品、エンドユーザー、地域別、2025年~2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2~3営業日
|
世界の多毛症市場規模は2024年に32億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに56億米ドルに達し、2025年から2033年にかけて5.97%の成長率(CAGR)を示すと予測しています。女性の過剰な体毛の存在に起因する身体障害の症例の増加が、市場を推進しています。
新たな治療オプション
より効果的で安全な治療法の開発が重視されるようになり、市場は先進的な治療法を経験しています。これに加えて、レーザー脱毛を含む、標的を絞った非侵襲的治療への傾斜の高まりも、重要な成長促進要因として作用しています。2024年8月、Skin Lattice Clinicは、インドのグルガオンで初めて、FDA認可のアルマ・チタニウム・プロ・レーザー脱毛技術を多毛症に導入し、皮膚科医療において重要な進歩を遂げました。高度な冷却システムと精密なターゲティングで有名なこの最先端技術は、最小限の不快感で優れた結果をもたらします。
診断と意識の向上
個人が診断と治療を求めるようになっています。この動向は、オンラインでの情報提供や教育キャンペーンによって後押しされ、早期発見やより積極的な管理につながっています。例えば、2024年8月、PCOS啓発協会とMilan Laser Hair Removalは、多嚢胞性卵巣症候群に罹患している人々の認知度を高め、擁護するために協力しました。これは多毛症市場展望レポートにプラスの影響を与えています。
美容治療に対する需要の高まり
過剰な発毛に対する長期的な解決策の採用が増加していることが、市場を活性化しています。特にレーザー脱毛は、副作用のリスクが比較的低く、効果的であることから人気を集めています。これが多毛症市場のシェアを拡大しています。2024年8月、シンガポールの美容業界のリーダーであるV Medical Aesthetics Groupは、医師が設計した技術ベースの育毛ソリューションを発表しました。
The global hirsutism market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 5.97% during 2025-2033. The growing cases of bodily disorders, owing to the presence of excessive body hair in women, are propelling the market.
Novel Treatment Options
The market is experiencing advanced treatment modalities, on account of the rising emphasis on developing more effective and safer therapies. Besides this, the growing inclination towards targeted and non-invasive therapies, including laser hair removal, is also acting as a significant growth-inducing factor. In August 2024, Skin Lattice Clinic made an important stride in dermatological care by becoming the first clinic in Gurgaon, India, to introduce the FDA-approved Alma Titanium Pro laser hair removal technology for hirsutism. This cutting-edge technology, renowned for its advanced cooling system and precision targeting, delivers exceptional results with minimal discomfort.
Increasing Diagnosis and Awareness
Individuals are seeking diagnosis and treatment. This trend is bolstered by the availability of information online and educational campaigns, thereby leading to earlier detection and more proactive management. For example, in August 2024, the PCOS Awareness Association and Milan Laser Hair Removal collaborated to raise awareness and advocate for those affected by polycystic ovarian syndrome. This is positively influencing the hirsutism market outlook report.
Rising Demand for Aesthetic Treatments
The growing adoption of long-term solutions to excessive hair growth is catalyzing the market. Laser hair removal, in particular, has gained traction due to its relatively low risk of side effects and effectiveness. This is expanding the hirsutism market share. In August 2024, V Medical Aesthetics Group, a leader in Singapore's aesthetics industry, introduced tech-based hair growth solutions designed by doctors.
Procedures can provide permanent or long-term hair reduction. On the other hand, medications play an important role, especially for those with underlying hormonal imbalances. Moreover, they include anti-androgens and oral contraceptives. This is elevating the hirsutism market statistics.
Topical hair removal products currently hold the largest hirsutism market demand
The inflating requirement for convenient and non-invasive solutions to manage unwanted hair is propelling the growth of the segment. For instance, Nair introduced a series of topical hair removal creams that cater to various skin types and areas of the body. This is increasing the hirsutism market revenue.
Hospitals are generally equipped with advanced diagnostic tools and comprehensive care facilities. Additionally, clinics, including endocrinology and dermatology practices, are also significant players in this market. According to the hirsutism market forecast report, this is propelling the growth of this segment.
North America currently dominates the hirsutism market outlook
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the hirsutism market analysis report, North America exhibits a clear dominance in the market. This can be attributed to the elevating awareness about the condition and the rising number of FDA approvals. In July 2024, Sun Pharmaceutical Industries received U.S. Food and Drug Administration (FDA) approval for Alopecia areata, which is characterized by hair loss.